132 related articles for article (PubMed ID: 38869005)
1. Data derived extrapolation factors (DDEFs) for rat to human interspecies extrapolation for the HPPD inhibitor mesotrione.
Pecquet AM; Bridgwood K; Cowie D; Hofstra A; Wu Y; Whalley S; Webb SD
Crit Rev Toxicol; 2024 Jun; ():1-12. PubMed ID: 38869005
[TBL] [Abstract][Full Text] [Related]
2. Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals.
Reichard JF; Maier MA; Naumann BD; Pecquet AM; Pfister T; Sandhu R; Sargent EV; Streeter AJ; Weideman PA
Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S67-78. PubMed ID: 27224509
[TBL] [Abstract][Full Text] [Related]
3. Data derived Extrapolation Factors for developmental toxicity: A preliminary research case study with perfluorooctanoate (PFOA).
Dourson ML; Gadagbui B; Onyema C; McGinnis PM; York RG
Regul Toxicol Pharmacol; 2019 Nov; 108():104446. PubMed ID: 31425727
[TBL] [Abstract][Full Text] [Related]
4. Integration of a plasma protein binding factor to the Chemical-Specific Adjustment Factor (CSAF) for facilitating the estimation of uncertainties in interspecies extrapolations when deriving health-based exposure limits for active pharmaceutical ingredients: Investigation of recent drug datasets.
Poulin P; Arnett R
Regul Toxicol Pharmacol; 2017 Dec; 91():142-150. PubMed ID: 29107009
[TBL] [Abstract][Full Text] [Related]
5. Evolution of chemical-specific adjustment factors (CSAF) based on recent international experience; increasing utility and facilitating regulatory acceptance.
Bhat VS; Meek MEB; Valcke M; English C; Boobis A; Brown R
Crit Rev Toxicol; 2017 Oct; 47(9):729-749. PubMed ID: 28681680
[TBL] [Abstract][Full Text] [Related]
6. The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective.
Gundert-Remy U; Sonich-Mullin C;
Sci Total Environ; 2002 Apr; 288(1-2):3-11. PubMed ID: 12013545
[TBL] [Abstract][Full Text] [Related]
7. Determination of the Association between Mesotrione Sensitivity and Conformational Change of 4-Hydroxyphenylpyruvate Dioxygenase via Free-Energy Analyses.
Munei Y; Hengphasatporn K; Hori Y; Harada R; Shigeta Y
J Agric Food Chem; 2023 Jun; 71(24):9528-9537. PubMed ID: 37277962
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers.
Hall MG; Wilks MF; Provan WM; Eksborg S; Lumholtz B
Br J Clin Pharmacol; 2001 Aug; 52(2):169-77. PubMed ID: 11488774
[TBL] [Abstract][Full Text] [Related]
9. Physiological and Molecular Characterization of Hydroxyphenylpyruvate Dioxygenase (HPPD)-inhibitor Resistance in Palmer Amaranth (
Nakka S; Godar AS; Wani PS; Thompson CR; Peterson DE; Roelofs J; Jugulam M
Front Plant Sci; 2017; 8():555. PubMed ID: 28443128
[TBL] [Abstract][Full Text] [Related]
10. Predictive toxicodynamics: Empirical/mechanistic approaches.
Frazier JM
Toxicol In Vitro; 1997 Oct; 11(5):465-72. PubMed ID: 20654336
[TBL] [Abstract][Full Text] [Related]
11. Bridging the Data Gap From
Zhang Q; Li J; Middleton A; Bhattacharya S; Conolly RB
Front Public Health; 2018; 6():261. PubMed ID: 30255008
[TBL] [Abstract][Full Text] [Related]
12. A biological characteristic extrapolation of compound toxicity for different developmental stage species with toxicokinetic-toxicodynamic model.
Gao Y; Xie Z; Feng M; Feng J; Zhu L
Ecotoxicol Environ Saf; 2020 Oct; 203():111043. PubMed ID: 32888597
[TBL] [Abstract][Full Text] [Related]
13. Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.
Mallick P; Song G; Efremenko AY; Pendse SN; Creek MR; Osimitz TG; Hines RN; Hinderliter P; Clewell HJ; Lake BG; Yoon M; Moreau M
Toxicol Sci; 2020 Aug; 176(2):460-469. PubMed ID: 32421774
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase inhibition in electric eel and human donor blood: an in vitro approach to investigate interspecies differences and human variability in toxicodynamics.
Kasteel EEJ; Nijmeijer SM; Darney K; Lautz LS; Dorne JLCM; Kramer NI; Westerink RHS
Arch Toxicol; 2020 Dec; 94(12):4055-4065. PubMed ID: 33037899
[TBL] [Abstract][Full Text] [Related]
15. Magnitude and mechanistic determinants of the interspecies toxicokinetic uncertainty factor for organic chemicals.
Pelekis M; Krishnan K
Regul Toxicol Pharmacol; 2004 Dec; 40(3):264-71. PubMed ID: 15546680
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 4-hydroxyphenylpyruvate dioxygenases, inhibition by herbicides and engineering for herbicide tolerance in crops.
Hawkes TR; Langford MP; Viner R; Blain RE; Callaghan FM; Mackay EA; Hogg BV; Singh S; Dale RP
Pestic Biochem Physiol; 2019 May; 156():9-28. PubMed ID: 31027586
[TBL] [Abstract][Full Text] [Related]
17. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
Bokkers BG; Slob W
Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of a rice triketone dioxygenase gene confers mesotrione tolerance in soybean.
Dai S; Georgelis N; Bedair M; Hong YJ; Qi Q; Larue CT; Sitoula B; Huang W; Krebel B; Shepard M; Su W; Kretzmer K; Dong J; Slewinski T; Berger S; Ellis C; Jerga A; Varagona M
Pest Manag Sci; 2022 Jul; 78(7):2816-2827. PubMed ID: 35395133
[TBL] [Abstract][Full Text] [Related]
19. Distributions for time, interspecies and intraspecies extrapolation for deriving occupational exposure limits.
Dilger M; Schneider K; Drossard C; Ott H; Kaiser E
J Appl Toxicol; 2022 May; 42(5):898-912. PubMed ID: 35187686
[TBL] [Abstract][Full Text] [Related]
20. Quantitative In Vitro-to-In Vivo Extrapolation for Mixtures: A Case Study of Superfund Priority List Pesticides.
Valdiviezo A; Luo YS; Chen Z; Chiu WA; Rusyn I
Toxicol Sci; 2021 Aug; 183(1):60-69. PubMed ID: 34142158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
